HomeCompareBAEIX vs JNJ

BAEIX vs JNJ: Dividend Comparison 2026

BAEIX yields 27.72% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BAEIX wins by $95.9K in total portfolio value
10 years
BAEIX
BAEIX
● Live price
27.72%
Share price
$16.85
Annual div
$4.67
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$115.9K
Annual income
$14,318.66
Full BAEIX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — BAEIX vs JNJ

📍 BAEIX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBAEIXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BAEIX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BAEIX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BAEIX
Annual income on $10K today (after 15% tax)
$2,356.09/yr
After 10yr DRIP, annual income (after tax)
$12,170.86/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, BAEIX beats the other by $11,467.25/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BAEIX + JNJ for your $10,000?

BAEIX: 50%JNJ: 50%
100% JNJ50/50100% BAEIX
Portfolio after 10yr
$68.0K
Annual income
$7,573.22/yr
Blended yield
11.14%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

BAEIX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BAEIX buys
0
JNJ buys
0
No recent congressional trades found for BAEIX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBAEIXJNJ
Forward yield27.72%3.36%
Annual dividend / share$4.67$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$115.9K$20.0K
Annual income after 10y$14,318.66$827.78
Total dividends collected$76.7K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: BAEIX vs JNJ ($10,000, DRIP)

YearBAEIX PortfolioBAEIX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$13,472$2,771.87$10,676$355.77+$2.8KBAEIX
2$17,905$3,489.93$11,407$389.39+$6.5KBAEIX
3$23,493$4,334.86$12,198$426.53+$11.3KBAEIX
4$30,453$5,315.70$13,056$467.62+$17.4KBAEIX
5$39,025$6,439.78$13,987$513.12+$25.0KBAEIX
6$49,469$7,712.48$14,998$563.56+$34.5KBAEIX
7$62,069$9,136.99$16,098$619.52+$46.0KBAEIX
8$77,128$10,714.20$17,295$681.69+$59.8KBAEIX
9$94,969$12,442.67$18,599$750.82+$76.4KBAEIX
10$115,936$14,318.66$20,022$827.78+$95.9KBAEIX

BAEIX vs JNJ: Complete Analysis 2026

BAEIXStock

The investment seeks capital growth and current income. The fund normally invests at least 80% of its net assets plus borrowings for investment purposes in equity securities. It invests, under normal market conditions, primarily in dividend-paying equity securities, in particular common stocks of companies with a history of increasing dividend rates. The fund may also invest in U.S. traded common stocks of foreign companies, including American Depositary Receipts.

Full BAEIX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this BAEIX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BAEIX vs SCHDBAEIX vs JEPIBAEIX vs OBAEIX vs KOBAEIX vs MAINBAEIX vs ABBVBAEIX vs MRKBAEIX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.